Compounds > remoxipride

Page last updated: 2024-08-23

remoxipride and Parkinson Disease

remoxipride has been researched along with Parkinson Disease in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Drukarch, B; Goosen, C; Sahadat, MC; Stoof, JC; Vermeulen, RJ; Wolters, EC	1
George, A; Gray, P; Grimes, JD; Mendis, T; Mohr, E; Rusk, IN	1
Duff, J; Lang, AE; Sandor, P	1
Angus, C; Lang, AE; Sandor, P; Singal, S	1
Casey, DE; Gerlach, J	1

Trials

1 trial(s) available for remoxipride and Parkinson Disease

Article	Year
Remoxipride in the treatment of levodopa-induced psychosis. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:5 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dopamine Antagonists; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Psychoses, Substance-Induced; Remoxipride	1996

Other Studies

4 other study(ies) available for remoxipride and Parkinson Disease

Article	Year
The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys. European journal of pharmacology, 1993, Apr-22, Volume: 235, Issue:1 Topics: Analysis of Variance; Animals; Benzazepines; Disease Models, Animal; Dopamine Agents; Ergolines; Macaca mulatta; Male; Motor Activity; MPTP Poisoning; Parkinson Disease; Quinpirole; Remoxipride	1993
Symptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxipride. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2 Topics: Aged; Aged, 80 and over; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Limbic System; Long-Term Care; Male; Mesencephalon; Middle Aged; Parkinson Disease; Pilot Projects; Psychoses, Substance-Induced; Receptors, Dopamine D2; Remoxipride	1994
Remoxipride in Parkinson's disease: differential response in patients with dyskinesias fluctuations versus psychosis. Clinical neuropharmacology, 1995, Volume: 18, Issue:1 Topics: Aged; Female; Hallucinations; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Psychotic Disorders; Remoxipride	1995
Remoxipride, a new selective D2 antagonist, and haloperidol in cebus monkeys. Progress in neuro-psychopharmacology & biological psychiatry, 1990, Volume: 14, Issue:1 Topics: Animals; Antipsychotic Agents; Arousal; Benzamides; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Haloperidol; Male; Motor Activity; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine; Receptors, Dopamine D2; Remoxipride	1990